These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25143734)

  • 1. Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles.
    Omwoyo WN; Ogutu B; Oloo F; Swai H; Kalombo L; Melariri P; Mahanga GM; Gathirwa JW
    Int J Nanomedicine; 2014; 9():3865-74. PubMed ID: 25143734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine.
    Singh KK; Vingkar SK
    Int J Pharm; 2008 Jan; 347(1-2):136-43. PubMed ID: 17709216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, characterization and antimalarial efficacy of PEGylated galactosylated nano lipid carriers of primaquine phosphate.
    Baruah UK; Gowthamarajan K; Ravisankar V; Karri VVSR; Simhadri PK; Singh V; Babu PP
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1809-1829. PubMed ID: 29087218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primaquine Loaded Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsion (NE): Effect of Lipid Matrix and Surfactant on Drug Entrapment, in vitro Release, and ex vivo Hemolysis.
    Wu KW; Sweeney C; Dudhipala N; Lakhani P; Chaurasiya ND; Tekwani BL; Majumdar S
    AAPS PharmSciTech; 2021 Sep; 22(7):240. PubMed ID: 34590195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies.
    Chadha R; Gupta S; Pathak N
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1538-46. PubMed ID: 22348223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicological study of the primaquine phosphate loaded chitosan nanoparticles in mice.
    Rajera R; Nagpal K; Singh SK; Mishra DN
    Int J Biol Macromol; 2013 Nov; 62():18-24. PubMed ID: 23973494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles.
    Omwoyo WN; Melariri P; Gathirwa JW; Oloo F; Mahanga GM; Kalombo L; Ogutu B; Swai H
    Nanomedicine; 2016 Apr; 12(3):801-809. PubMed ID: 26724538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel.
    Pandita D; Ahuja A; Lather V; Benjamin B; Dutta T; Velpandian T; Khar RK
    AAPS PharmSciTech; 2011 Jun; 12(2):712-22. PubMed ID: 21637945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of antimalarial potential of polyphosphazene linked combination therapy of primaquine and dihydroartemisinin.
    Kumar S; Singh RK; Sharma R; Murthy RS; Bhardwaj TR
    Eur J Pharm Sci; 2015 Jan; 66():123-37. PubMed ID: 25312346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction with Modified Cyclodextrin as a Way to Increase the Antimalarial Activity of Primaquine.
    Torres LH; de Carvalho LB; de Fátima Abreu Venceslau A; Jaime C; de Matos Alves Pinto L
    Curr Drug Discov Technol; 2020; 17(5):670-681. PubMed ID: 31438828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver.
    Gomes F; Ribeiro AC; Sanches GS; Borges HS; Takahashi LAU; Daniel-Ribeiro CT; Tedesco AC; Nascimento JWL; Carvalho LJM
    Antimicrob Agents Chemother; 2024 May; 68(5):e0091523. PubMed ID: 38517190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections.
    Li Q; O'Neil M; Xie L; Caridha D; Zeng Q; Zhang J; Pybus B; Hickman M; Melendez V
    Malar J; 2014 Apr; 13():141. PubMed ID: 24731238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method.
    Nabi-Meibodi M; Vatanara A; Najafabadi AR; Rouini MR; Ramezani V; Gilani K; Etemadzadeh SM; Azadmanesh K
    Colloids Surf B Biointerfaces; 2013 Dec; 112():408-14. PubMed ID: 24036624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nanoparticles.
    Jia Y; Ji J; Wang F; Shi L; Yu J; Wang D
    Drug Deliv; 2016 May; 23(4):1317-25. PubMed ID: 25371296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: Pharmacokinetics, toxicological and in vivo anti-malarial activity.
    Aditya NP; Patankar S; Madhusudhan B; Murthy RS; Souto EB
    Eur J Pharm Sci; 2010 Aug; 40(5):448-55. PubMed ID: 20493255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactose-Anchored Gelatin Nanoparticles for Primaquine Delivery and Improved Pharmacokinetics: A Biodegradable and Safe Approach for Effective Antiplasmodial Activity against P. falciparum 3D7 and in Vivo Hepatocyte Targeting.
    Kumar H; Gothwal A; Khan I; Nakhate KT; Alexander A; Ajazuddin ; Singh V; Gupta U
    Mol Pharm; 2017 Oct; 14(10):3356-3369. PubMed ID: 28836792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and in vitro cytotoxicity of Fenofibrate and Nabumetone loaded solid lipid nanoparticles.
    Kumar R; Singh A; Sharma K; Dhasmana D; Garg N; Siril PF
    Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110184. PubMed ID: 31753394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil.
    Shi F; Zhao JH; Liu Y; Wang Z; Zhang YT; Feng NP
    Int J Nanomedicine; 2012; 7():2033-43. PubMed ID: 22619540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.